If you continue without changing your settings, we’ll assume you’re happy to receive all cookies from the BMA website. Find out more about cookies
When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalised web experience.
Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms.
You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
These cookies are required
These cookies allow us to know which pages are the most and least popular and see how visitors move around the site. All information we collect is anonymous unless you actively provide personal information to us.
If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
These cookies allow a website to remember choices you make (such as your user name, language or the region you're in) and tailor the website to provide enhanced features and content for you.
For example, they can be used to remember certain log-in details, changes you've made to text size, font and other parts of pages that you can customise. They may also be used to provide services you've asked for such as watching a video or commenting on a blog. These cookies may be used to ensure that all our services and communications are relevant to you. The information these cookies collect cannot track your browsing activity on other websites.
Without these cookies, a website cannot remember choices you've previously made or personalise your browsing experience meaning you would have to reset these for every visit. In addition, some functionality may not be available if this category is switched off.
Our websites sometimes integrate with other companies’ sites. For example, we integrate with social networking sites such as Twitter and Facebook, to make it easier for you to share what you have read. These sites place their own cookies on your browser as a result of us including their icons and ‘like’ or ‘share’ buttons on our sites.
Influenza A virus is a highly contagious respiratory infection that can cause a host of unpleasant symptoms and even death in some. Influenza can be particularly serious for the elderly and those with chronic heart and lung diseases, who are at higher risk of becoming more severely ill. Vaccines against influenza currently exist, but in order to make these scientists have to predict in advance which strain they think will be circulating the following year. As influenza virus can mutate and change in the time it takes to manufacture a vaccine, vaccination often fails to protect people against a newly mutated versions of a virus. An additional problem is that even when scientists correctly predict a viral strain, the vaccine may still be poor at generating immune responses to the virus. It is therefore important to develop new and improved vaccines that provide broader protection against a wide range of influenza viruses.
One approach to tackle these problems is improving our understanding of how the body’s immune system recognises and responds to the flu virus. I hope to do this by deciphering the information which is transferred by tiny information pods called exosomes, released by almost all cells in the body. Exosomes are nano-sized cell shuttles that communicate important information from cell to cell. We know that their messages can be altered during infection, and possibly when responding to vaccination. Because of this, there is great potential to manipulate their interactions with the cells of the immune system to improve vaccine responses.
My research aims to study exosome communication in two ways. One approach is to better understand what is contained in exosomes following vaccination. In other words, what are the messages being transferred from cell to cell and how do they affect the immune response? Another approach is to exploit the cell:cell transfer properties of exosomes and hijack these shuttles by designing vaccines which can artificially deliver fragments of the influenza virus (called proteins) to exosomes. Through doing this we hope that more immune cells will recognise influenza proteins and become activated, dramatically improving the body’s immune response and providing greater protection. We are particularly interested in using fragments of the influenza virus which do not mutate so that these "universal influenza vaccines" could generate immune responses capable of protecting against a diverse range of strains.
The HC Roscoe grant from the BMA foundation has allowed me to pursue this research project and to establish a collaboration between the Jenner Institute, University of Oxford and Icahn School of Medicine at Mount Sinai, New York, where I am currently working within Prof Peter Palese's world renowned influenza virology laboratory. The in-house expertise and complementary approaches to generating universal influenza vaccines at Mount Sinai ensure that this study will lead to the design of more effective influenza vaccines for clinical investigation and pandemic preparedness, with the potential to beneficially impact patient health, society and the economy.